1-Hexanol

1-Hexanol

SCHEMBL566306

CCCCCCO.OC1CCCCC1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.56
TSHR P16473 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HSD17B10 Q99714 1/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.52
NAAA Q02083 2/20 0.42
CYP1A2 P05177 1/20 0.41
SIGMAR1 Q99720 2/20 0.41
EPHX1 P07099 4/20 0.40
EPHX2 P34913 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nonanol SCHEMBL28874685 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
Cetostearyl Alcohol SCHEMBL9306310 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
Myristyl Alcohol SCHEMBL20943422 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
Octanol SCHEMBL27554458 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
Octanol SCHEMBL1902204 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
Dodecanol SCHEMBL5587314 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
1-Heptanol SCHEMBL1419499 1.00 LMNA (0.56) LMNATSHRALDH1A1HSD17B10MEN1
1-Hexanol SCHEMBL11613519 0.98 LMNA (0.54) LMNATSHRALDH1A1HSD17B10MEN1
Decanol SCHEMBL28320734 0.98 LMNA (0.59) LMNATSHRALDH1A1HSD17B10MEN1
Cyclohexanol SCHEMBL10527201 0.98 SMN1; SMN2 (0.55) LMNATSHRALDH1A1HSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-H1265-H Formulations of 2-(decylthio)ethanamine THE DOW CHEMICAL COMPANY (US) 1993-12-07 US claimed
CN-115152044-A Color conversion pixel, composition for color conversion pixel, and display device including the color conversion pixel 东友精细化工有限公司 2022-10-04 CN disclosed
CN-106902879-B A kind of preparation method and applications of Co@C@MOF magnetic catalyst 湖北大学 2019-09-10 CN disclosed
EP-2601331-B1 METHOD AND DEVICE FOR CARBOXYLIC ACID PRODUCTION FIELD UPGRADING LTD (CA) 2018-06-20 EP disclosed
CN-107614510-A Iridium complex compound, organic electroluminescent element containing iridium complex compound, display device, and lighting device 三菱化学株式会社 2018-01-19 CN disclosed
CN-104411743-B Polymer compound, charge-transporting polymer, composition for organic electroluminescent element, organic EL display device, and organic EL lighting 三菱化学株式会社 2016-11-02 CN disclosed
US-20150233002-A1 METHOD AND DEVICE FOR CARBOXYLIC ACID PRODUCTION FIELD UPGRADING LIMITED (CA) 2015-08-20 US disclosed
US-9057137-B2 Method and device for carboxylic acid production CERAMATEC, INC. (US) 2015-06-16 US disclosed
EP-2601331-A2 METHOD AND DEVICE FOR CARBOXYLIC ACID PRODUCTION Ceramatec, Inc (US) 2013-06-12 EP disclosed
WO-2012018418-A2 METHOD AND DEVICE FOR CARBOXYLIC ACID PRODUCTION CERAMATEC, INC. (US) 2012-02-09 WO disclosed
EP-2318364-A2 PREPARATION OF 3-PYRROLE SUBSTITUTED 2-INDOLINONE DERIVATIVES Generics [UK] Limited (GB) 2011-05-11 EP disclosed
US-20110089380-A1 Fullerene Multi-Adduct Compositions SOLENNE BV 2011-04-21 US disclosed
WO-2010001167-A2 NOVEL PROCESS GENERICS [UK] LIMITED (GB) 2010-01-07 WO disclosed
EP-1092056-A1 DRY CLEANING METHOD AND MODIFIED SOLVENT Greenearth Cleaning, LLC (US) 2001-04-18 EP disclosed
WO-2000004222-A1 DRY CLEANING METHOD AND MODIFIED SOLVENT GREENEARTH CLEANING, LLC (US) 2000-01-27 WO disclosed
US-5908720-A CARBON BLACK COATED WITH A RESIN OBTAINED FROM ONE OR MORE POLYMERIZABLE MONOMERS HAVING AT LEAST ONE REACTIVE GROUP SELECTED FROM THE GROUP CONSISTING OF EPOXY, THIOEPOXY, OXAZOLINE, AZILIDINE AND HYDROXYALKYL AMIDE GROUPS TOKYO OHKA KOGYO CO., LTD. (JP) 1999-06-01 US disclosed
US-5900483-A Process for the separation of phenyluracil compounds NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1999-05-04 US disclosed
US-4284772-A ULTRAVIOLET RADIATION STABILIZERS FOR POLYMERS AKZONA INCORPORATED (US) 1981-08-18 US disclosed
US-4267383-A USING A COMPLEX CATALYST FROM A TRIARYL PHOSPHINE AND A RHODIUM CARBONYL HYDRIDE OR CHLORIDE CELANESE CORPORATION (US) 1981-05-12 US disclosed
US-4204060-A ANTIOXIDANTS, UV STABILIZERS AKZONA INCORPORATED (US) 1980-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110089380-A1 Fullerene Multi-Adduct Compositions FTO, AKR1B10, DNMT1 LMNA 1168/4885TSHR 4679/4885ALDH1A1 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.